BSE - Delayed Quote INR
Sanofi Consumer Healthcare India Limited (SANOFICONR.BO)
4,938.90
-1.20
(-0.02%)
At close: April 25 at 3:29:34 PM GMT+5:30
Breakdown
TTM
12/31/2024
12/31/2023
Total Revenue
7,162,000
7,162,000
5,443,000
Cost of Revenue
2,288,000
2,288,000
1,940,000
Gross Profit
4,874,000
4,874,000
3,503,000
Operating Expense
2,189,000
2,189,000
1,331,000
Operating Income
2,685,000
2,685,000
2,172,000
Net Non Operating Interest Income Expense
78,000
78,000
38,000
Pretax Income
2,468,000
2,468,000
2,193,000
Tax Provision
658,000
658,000
544,000
Net Income Common Stockholders
1,810,000
1,810,000
1,649,000
Diluted NI Available to Com Stockholders
1,810,000
1,810,000
1,649,000
Basic EPS
--
78.59
71.60
Diluted EPS
--
78.59
71.60
Basic Average Shares
--
23,030.62
23,030.62
Diluted Average Shares
--
23,030.62
23,030.62
Rent Expense Supplemental
27,000
27,000
2,000
Total Expenses
4,477,000
4,477,000
3,271,000
Net Income from Continuing & Discontinued Operation
1,810,000
1,810,000
1,649,000
Normalized Income
2,018,282.01
2,018,282.01
1,662,534.88
Interest Income
109,000
109,000
40,000
Interest Expense
40,000
40,000
2,000
Net Interest Income
78,000
78,000
38,000
EBIT
2,508,000
2,508,000
2,195,000
EBITDA
2,553,000
2,553,000
2,213,000
Reconciled Cost of Revenue
2,288,000
2,288,000
1,940,000
Reconciled Depreciation
45,000
45,000
18,000
Net Income from Continuing Operation Net Minority Interest
1,810,000
1,810,000
1,649,000
Total Unusual Items Excluding Goodwill
-284,000
-284,000
-18,000
Total Unusual Items
-284,000
-284,000
-18,000
Normalized EBITDA
2,837,000
2,837,000
2,231,000
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
-75,717.99
-75,717.99
-4,465.12
12/31/2023 - 10/8/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade